甲减致血脂异常的治疗

5
?

32

0??N

M? ?ù

SpecialForumS

ó?sè
^?ó5%h￥×

12By
í
V7°m?|
ì￥

1?bó?sè￥eys1e??

????b????ó?sè ''

v?s
^??t
¤?%h
?á


Kèn￥ ?UhaJF??

h|?(e?Jh)#
¤?
/#%h

?
t0t9??Yó?}?7

?áó?sèb?
Jh
^?á

???ó?sè￥èneyb

Jháó?sè￥?


3 ?4
￥JF
í;?

\é?%???}?￥K
?
?β-?

-β-J-?=
???￡
?A(HMG-

CoA)?e
?￥??
]
H?4ú

HMG-CoA?e
?￥?
V7 V

\é?%?￥??
??4ú7α

??
?#§ y
?￥?
\é?%

??1??
?bJF
í??

9F%
?
á??a?%?

(low-densitylipoproteincholesterol


LDL-C)
s8
?"#?
\é

LDL-C?3
i?2?
?[


?(triglyceridelipase
HSL)
\é

?[??#?[
?￥?b
Pó}

9?%?(totalcholesterol
TC)
￡ü

??b

Jh
H
JF
í
￡ü?

?
?%?￥??T¨<??3

#?T¨
óbTC
￡ü
6ú
O

??LDL-C
s8
?"h

LDL-C

?3
?h
¤
i
6úb#

Jh
HB?VC1TCaLDL-Ca

ApoB?Lp(a)
6ú
μ
H V?μ?

2?
(triglyceride
TG)￥
6ú


ú
á??a?%?(high-density

lipoproteincholesterol
HDL-C)B?

í
üAM?

[1]

b]
H
ù?9?C


ú?%?ó????Jh￥?h
q

?14.3%
?e??Jh3.7%

[2]

b

Jháó?sè￥í



JF
í

1

W@t
EM} 7
S
J

F
íX¨?Jháó?sè￥í


b"-
JF
í V??Jh?

?￥ó?sèXr?
Mbù?

V
ü
PJF
í(levothyroxine


LT

4

)í
8? V
P?75%￥Jh??

uE +`?ê
8 ?D

y=s
? S??
??D


=b?êvD?
q
p
V
3

?
=b?ê
8
"5DDù?

y=s
?}?ù?
?
?éb

?
3?l
DE
?S

?
3"d5éyT?b??

SE1? SDáaa


EB?|êaS=?T?[

"bSE S/é?=??

[
?ê
8 S/B??

[

8?)=??[b?

V
?ó?é
?4$
?

ó?éb

T

reatmentofhypothyroidisminduced

bybloodlipidabnormality

Jháó?sè￥í


?ê
8 ?Dy=s
? S

uE +

?ms ?|

``óDS
M
?`"``ócI|` 


1oM

JF??h|?
ó?sè
0tí


5
?



M? ?ù



0??N



33

SpecialForum

ó??ˉ?èb??Jh??
???ó5%h￥ú

2|?
 ??×g?￥ ''üao?#?μúóa

h￥???
? ?Jh???Yèwi
P¨DLT

4

ó?￥??í
b

"-￥ù?éZ1Jháó?sè￥í
4


֐4
??0tDLT

4

￥ ó??¨
"5Z
? V

[4÷mb



eR ?0t


eR ?0t???ó5
YqZ
?￥T¨X
P

?1??%?í
￥áS

eR ?0tJháó

?sè￥í
?g?T1
nêby1
eR ?0t VE

HMG-CoA?e
??
7LT

4

VYVLDL-C
s

87á
??3?%?

?[
eR ?0t ó?LT

4

V
ü

A??LDL-Cb]
H

eR ?0t? μ
üA￥ F

T¨
V7 V?JF7?áJh￥??9
^μ

m￥

[3]

b


eR ?0t
^???%?1???μr￥0tb

?
^
Jh?? V??
?￥
üA
6úbe?

?Jh¤
sv4

eR ?0tí

H
.àμ V??
3

??·3

[4]

byN
X
P¨
eR ?0t7J??

?è￥??
P¨LT

4

9}í
XT07ˉ
P¨
e

R ?0t￥????ì?è
0
?t|?
^?
3
eR

?0t
?áh￥ú2|?b3á??¨
eR ?0t

í
￥??
?Ce???#
HáóD
=[

?
^??
3h
i#
H??0tí
b31


P¨???0
sv4

eR ?0t￥??3ê4


e9}￥n
@b

Jh??
''
P
^e
"5Jh??
?T
^M


-<65
?aTSHú?10mIU/L￥?ó5%h￥ú2|

?
??é?M?í


[5]

b?
eR ?0t ó? I

??
?JF
í￥? óí
 V]
HT¨??%?￥

??a
l?b"

^ Vê4￥Z?-Bb

K?ù??C
JF
í ?
?tepotiome ó?

?B
eR-?B
eRí
ú?%?ó???
 V
ü

A??á?
???￥??ar32%[


[6]

b??J

F
í ?
?t
P¨??
O??Mó}TSHi
"

-
?43??#??￥?
Q?
 V??1

í
Jháó?sè￥B??￥??μr￥0tb


I ??


I ??

^B?ü?￥??
?>?4
l

? Vê4?￥2????
?

[7]



Pó}LDL-C￥b

"9Fbíù￥?A
U
| ?
??
? V?T

1?|s0YVG} ó?a
s8TGR5Y
^?Y?


h{
?á%=ì

?F
?(cyclicadenosine

monophosphate
cAMP)
￡ü
6ú
?á??JF

e?
?
3?9Fb+s???
?>?4 I ??
 V


P=÷???
?/??40%
 VO?%??1?

?
?9F
V7??LDL-Cr20%

[8]

bN?

?D
e

R ?0t ó¨? V[??ú
ùCQ??a(Creactive

protein
CRP)byN
 I ??
 ó?
eR ?0t?J

F
í
^í
Jháó?sè￥μrn
@b? I ??


 VDLT

4

2?
??
l
#??¨LT

4

1j4h

a
P¨ I ??
bèn?
Q?1L
Yah??


a′Dae?b


?0

?0í
ó?sèZ
?μ V L￥
"5
r?


z￥???
?¨ZLaNì? ÷aGV?zbè

¨￥??0 ???aa?A?aó? B?b0??


ü?4í
ú?ó?￥??0tμ??
''6?a

????
néb?0??￥μr?s ?|
&0a

?" ?90a
2¤a6?R?a %
ü0av?

pav
×
íaˉp?30??
 V? ó?sè￥?

] ??é?ê4b?0í
 ó??¨
H
3?i V

?￥?
Q?μt
??￡aúóaúU
?ó?a


h???
aaé
?]?h?? ??b



3Z
T??


3Z
T???1 ?
? e?8×b|8× e

??èS?= V??ó?sè?
3￥2B
9μù

??i?×g?￥Jh??ó?sè￥??b??

??
Jb?? ? e?9￡

? ?ó?!
í
h



Jt??[
-
^??[
??
J?
?]1×b

è?b??μ?
p￥?μù????[}?
?

?óTCaTGaLDL-C

6úHDL-C
? Vi

4ú???[%??a?
?￥?
\é?[

5
?

34

0??N

M? ?ù

SpecialForumS

s3
9F3 ??[
?￥? ?¨
°¤W¤1?

?ó?}? ?béμ?K?b
@?hDù?A
U


μ? V
üA??ó?}? ?
i??3?h?Bb

?ú"4÷?
?
? VO?[F?
db?

[
?

Pé#??TG￥-8?
á??a?%?

(verylow-densitylipoproteincholesterol
VLDL-C)9

F
i
PVLDL-C#?
?± ìVó?b"h
¤7?á

TG
6ú

[9]

b

9-
Jháó?sè￥???
"LT

4

?


3Z
T???
? I
n?
eR ?0tí
b?

LDL-Cˉ?rS
5wi ó?
e??0tbD
3

óíJháó?sè????í
-? s
3ò ?

0tW￥MoT¨a0
s?????b ó?í
?

μú?ó5%h?B￥Jháó?sè?? ?
a÷1

A1

[10]

b

? IóD

[1]BauerDC,EttingerB,BrownerWS.Thyroidfunctionsandserum

lipidsinolderwomen:apopulation-basedstudy[J].AmJMed,1998,

104(6):546-551.

[2]TagamiT,KimuraH,OhtaniS,etal.Multi-centerstudyonthe

prevalenceofhypothyroidisminpatientswithhypercholesterolemia[J].

EndocrJ,2011,58(6):449-557.

[3]KrysiakR,OkopienB.Theeffectofsimvastatinonlymphocyte

secretoryfunctioninpatientswithimpairedfastingglucose[J].J

CardiovascPharmacol,2010,56:491-497.

[4]KiernanTJ,RochfordM,McDermottJH.Simvastatininduced

rhabdomyolysisandanimportantclinicallinkwithhypothyroidism[J].

IntJCardiol,2007,119,374-376.

[5]RotondiM,denElzenWP,BauerDC,etal.Subclinicalhypothyroidism

andtheriskofcoronaryheartdisease[J].JAmMedAssoc,2010,304:

1365-1374.

[6]LadensonPW,KristensenJD,RidgwayEC,etal.Useofthethyroid

hormoneanalogueeprotiromeinstatin-treateddyslipidemia[J].NEngl

JMed,2010,362:906-916.

[7]WatanabeH,HoutenSM,MatakiC,etal.Bileacidsinduceenergy

expenditurebypromotingintracellularthyroidhormoneactivation[J].

Nature,2006,439:484-489.

[8]InsullWJ.Clinicalutilityofbileacidsequestrantsinthetreatmentof

dyslipidemia:ascientifcreview[J].SouthMedJ,2006,99:257-273.

[9]tE
ù.
L¨ó?D(?1?)[M].?:|
??
3?
,2010.

[10]DuntasL,KolovouG.Optionsforthetreatmentofhyperlipidemia

intype2diabetesmellitusandhypothyroidism:loweringthe

cardiovascularrisk[J].FutureCardiol,2011,7(2):137-144.


là°ù
2012-2-20¤
l°ù
2012-3-15


¤?:


? IóD

[1]RapaA,MonzaniA,MoiaS,etal.Subclinicalhypothyroidismin

childrenandadolescents:awiderangeofclinical,biochemical,and

geneticfactorsinvolved[J].JClinEndocrinolMetab,2009,94(7)


2414-2420.

[2]KaplowitzPB.Subclinicalhypothyroidisminchildren:normal

variationorsignofafailingthyroidgland[J]?IntJPediatrEndocrinol,

2010:1-8.

[3]RagoT,ChiovatoL,GrassoL,etal.Thyroidultrasonographyasa

toolfordetectingthyroidautoimmunediseasesandpredictingthyroid

dysfunctioninapparentlyhealthysubjects[J].JEndocrinolInvest,

2001,24:763-769.

[4]RapaA,MonzaniA,MoiaS,etal.Subclinicalhypothyroidismin

childrenandadolescents:awiderangeofclinical,biochemical,and

geneticfactorsinvolved[J].JClinEndocrinolMetab,2009,94(7):

2414-2420.

[5]O''GradyMJ,CodyD.Subclinicalhypothyroidisminchildhood[J].

ArchDisChild,2011,96(3):280-284.

[6]DeLucaF,WasniewskaM,ZirilliG,etal.Attheendofatwo-year

follow-upelevatedTSHlevelsnormalizeorremainunchangedinmost

thechildrenwithsubclinicalhypothyroidism[J].ItalJPediatr,2010,

30(36):11.

[7]CerboneM,BravaccioC,CapalboD,etal.Lineargrowtha

intellectualoutcomeinchildrenwithlong-termidiopaticsubclinical

hypothyroidism[J].EurJEndocrinol,2011,164(4):591-597.

[8]FavaA,OliverioR,GiulianoS,etal.Clinicalevolutionofautoimmune

thyroiditisinchildrenandadolescents[J].Thyroid,2009,19(4):361-367.

[9]MarkovicS,KosticG,IqrutinovicZ,etal.Hashimoto''sthyroiditisin

childrenandadolescents[J].SrpArhCelokLek,2008,136(5-6):262-266.

[10]LafranchiSH.Approachtothediagnosisandtreatmentofneonatal

hypothyroidism[J].JclinEndocrinolMetab,2011,96(10):2959-2967.

[11]
+Z ,?￡?,;D?,?.8`e
"5JF??h|?? ?￥

?Y#9}í
￥N′[J].?êD SvDD,2006,41(3):338-340.

[12]JensovskyJ,RuzickaE,SpackovaN,etal.Changesofeventrelatedpotential

andcognitiveprocessesinpatientswithsubclinicalhypothyroidismafter

thyroxinetreatment[J].EndocrRegul,2002,36(3):115-122.

[13]CalaciuraF,MottaRM,MiscioG,etal.Subclinicalhypothyroidisminearly

childhood:afrequentoutcomeoftransientneonatalhyperthyrotropinemia[J].

JClinEndocrinolMetab,2002,87(7):3209-3214.


là°ù
2012-3-20¤
s°ù
2012-4-8